American Bio Medica Corporation
American Bio Medica Corporation (ABMC) Revenue
Annual & quarterly revenue history · segment & region breakdown
ABMC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAmerican Bio Medica Corporation trailing twelve-month (TTM) revenue is $0.00B, a decrease of 58.84% year-over-year from $0.00B in FY2022.
Revenue trend
2022 – 2003 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.00B | -$0.00B | -58.84% |
| 2021-12-31 | $0.00B | -$0.00B | -46.52% |
| 2020-12-31 | $0.00B | +$0.00B | +13.46% |
| 2019-12-31 | $0.00B | -$0.00B | -5.60% |
| 2018-12-31 | $0.00B | -$0.00B | -21.20% |
| 2017-12-31 | $0.00B | -$0.00B | -12.39% |
| 2016-12-31 | $0.01B | -$0.00B | -11.21% |
| 2015-12-31 | $0.01B | -$0.00B | -13.29% |
| 2014-12-31 | $0.01B | -$0.00B | -18.09% |
| 2013-12-31 | $0.01B | -$0.00B | -4.81% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income American Bio Medica Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
American Bio Medica Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from American Bio Medica Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ABMC revenue · 4 questionsABMC's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 58.84% year-over-year from $0.00B in FY2022.
▸ Source: FMP · American Bio Medica Corporation SEC filings · GAAP · American Bio Medica Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026